Precision Wealth Strategies LLC Has $292,000 Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Precision Wealth Strategies LLC grew its position in HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 8.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,726 shares of the company’s stock after purchasing an additional 138 shares during the period. Precision Wealth Strategies LLC’s holdings in HCA Healthcare were worth $292,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Mount Yale Investment Advisors LLC lifted its position in shares of HCA Healthcare by 5.3% in the 1st quarter. Mount Yale Investment Advisors LLC now owns 5,178 shares of the company’s stock worth $1,298,000 after acquiring an additional 259 shares during the period. CI Investments Inc. lifted its position in shares of HCA Healthcare by 51.6% in the 1st quarter. CI Investments Inc. now owns 18,788 shares of the company’s stock worth $4,709,000 after acquiring an additional 6,392 shares during the period. CVA Family Office LLC lifted its position in shares of HCA Healthcare by 31.5% in the 1st quarter. CVA Family Office LLC now owns 605 shares of the company’s stock worth $152,000 after acquiring an additional 145 shares during the period. Commerce Bank lifted its position in shares of HCA Healthcare by 6.1% during the 4th quarter. Commerce Bank now owns 6,859 shares of the company’s stock worth $1,762,000 after buying an additional 392 shares during the period. Finally, Machina Capital S.A.S. bought a new position in shares of HCA Healthcare during the 1st quarter worth approximately $226,000. 65.75% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 2.4 %

NYSE:HCA opened at $194.06 on Friday. HCA Healthcare, Inc. has a 1 year low of $164.47 and a 1 year high of $279.02. The company has a current ratio of 1.55, a quick ratio of 1.32 and a debt-to-equity ratio of 87.46. The stock has a market cap of $55.70 billion, a price-to-earnings ratio of 9.33, a PEG ratio of 1.51 and a beta of 1.72. The stock has a 50-day moving average price of $205.76 and a two-hundred day moving average price of $214.90.

HCA Healthcare (NYSE:HCAGet Rating) last posted its quarterly earnings data on Friday, July 22nd. The company reported $4.21 earnings per share for the quarter, topping the consensus estimate of $3.67 by $0.54. The company had revenue of $14.82 billion during the quarter, compared to analysts’ expectations of $14.73 billion. HCA Healthcare had a return on equity of 833.68% and a net margin of 10.83%. HCA Healthcare’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $4.37 earnings per share. As a group, equities analysts expect that HCA Healthcare, Inc. will post 17.09 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 30th. Investors of record on Friday, September 16th will be issued a dividend of $0.56 per share. The ex-dividend date is Thursday, September 15th. This represents a $2.24 annualized dividend and a yield of 1.15%. HCA Healthcare’s payout ratio is presently 10.77%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Bank of America raised their target price on HCA Healthcare from $192.00 to $230.00 in a research report on Sunday, July 24th. Raymond James raised their target price on HCA Healthcare from $230.00 to $250.00 and gave the stock an “outperform” rating in a research report on Friday, September 16th. Stephens raised their price target on HCA Healthcare to $230.00 in a report on Monday, July 25th. Cowen dropped their price target on HCA Healthcare to $238.00 in a report on Monday, July 25th. Finally, Sanford C. Bernstein raised HCA Healthcare from a “market perform” rating to an “outperform” rating and dropped their price target for the company from $273.00 to $271.00 in a report on Thursday, May 26th. One research analyst has rated the stock with a sell rating, three have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $239.14.

Insider Buying and Selling

In related news, major shareholder Patricia F. Elcan bought 325 shares of the company’s stock in a transaction that occurred on Monday, July 25th. The shares were acquired at an average price of $198.66 per share, for a total transaction of $64,564.50. Following the completion of the acquisition, the insider now owns 89,337 shares of the company’s stock, valued at approximately $17,747,688.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 1.50% of the stock is currently owned by corporate insiders.

About HCA Healthcare

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAGet Rating).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.